NCT07225491|Recruiting
Spine Oncology Registry
A Prospective Registry of Patients Undergoing Surgical Decompression Followed by Radiation Therapy for Spine Tumors
Loading search results
A Prospective Registry of Patients Undergoing Surgical Decompression Followed by Radiation Therapy for Spine Tumors
Sponsor study identifier
Secondary identifiers
REGISTRY · CTRP (Clinical Trial Reporting Program)
OTHER · Ohio State University Comprehensive Cancer Center
observational
3,000
1 country
5
Study Start
November 24, 2025
Actual (reported)Primary Completion
December 31, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2037
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This is an observational study to evaluate hardware related and oncologic outcomes in adult patients with primary and metastatic spine disease undergoing separation surgery followed by radiation treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2037
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 14, 2025
Actual (reported)November 6, 2025
Actual (reported)November 24, 2025
Actual (reported)December 31, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 31, 2037
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Overall survival
12, 18, 24 months
Local control of treated lesion based on radiographic review
Patients will be classified as achieving local control if demonstrating response of treated spine lesion after treatment. Local control will be assessed by comparing the radiographic images after treatment and prospectively every 3 months for up to 24 months
3, 6, 9, 12, 15, 16, 21, 24 months
Progression free survival
3, 6, 9, 12, 15, 16, 21, 24 months
The study population will be comprised of patients with primary and metastatic spine disease who undergo surgery followed by radiation therapy. Patients may be enrolled regardless of previous local or systemic treatments received prior to enrollment in this registry. Patients may be enrolled regardless of other current local or systemic treatments of disease extent.
Indiana University
Indianapolis, Indiana, 46202, United States
University of Maryland,
Baltimore, Maryland, 21201, United States
University of Michigan
James B Elder, MD
Ohio State University
First Submitted
October 14, 2025
First Posted
November 6, 2025
Study Start
November 24, 2025
Actual (reported)Primary Completion
December 31, 2035
EstimatedSingle- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
Contact the study team to confirm eligibility.
Ann Arbor, Michigan, 48109, United States
Rutgers Robert wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2037
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
September 24, 2026
Record last verified: 2025-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: